| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
5,524,000 |
| Market
Cap: |
631.12(M) |
| Last
Volume: |
29,413 |
Avg
Vol: |
40,304 |
| 52
Week Range: |
$84.55 - $143.36 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ INDUSTRIAL |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Mesa Laboratories manufactures, develops, and sells quality control products and services. Co. is organized into four segments: Sterilization and Disinfection Control Division, which provides manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development Division, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis; Calibration Solutions Division, which develops, manufactures, and sells quality control and calibration products; and Clinical Genomics Division, which develops, manufactures, and sells genetic analysis tools used by labs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$100,000 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
1,500 |
10,500 |
46,373 |
| Total Sell Value |
$0 |
$168,540 |
$1,317,035 |
$8,243,267 |
| Total People Sold |
0 |
1 |
3 |
8 |
| Total Sell Transactions |
0 |
1 |
5 |
25 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Archbold Brian David |
SVP Continuous Improvement |
• – – |
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
70 |
302 |
|
- |
|
| Owens Gary M |
CEO |
• – – |
2020-06-15 |
4 |
D |
$226.72 |
$99,757 |
D/D |
(440) |
11,000 |
|
- |
|
| Owens Gary M |
CEO |
• – – |
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
11,440 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
30 |
63,731 |
|
- |
|
| Kelly David M |
Director |
– • – |
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
30 |
2,810 |
|
- |
|
| Guillemin Evan |
Director |
– • – |
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
30 |
35,878 |
|
- |
|
| Schmieder John Bradley |
Director |
– • – |
2020-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
30 |
73,467 |
|
- |
|
| Dwyer Robert V |
Director |
– • – |
2020-04-03 |
4 |
OE |
$58.51 |
$29,759 |
D/D |
378 |
36,074 |
|
- |
|
| Dwyer Robert V |
Director |
– • – |
2020-04-03 |
4 |
OE |
$97.78 |
$56,904 |
D/D |
490 |
36,564 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2020-02-27 |
4 |
OE |
$51.85 |
$222,913 |
D/D |
3,286 |
72,931 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2020-02-27 |
4 |
S |
$256.02 |
$435,746 |
D/D |
(1,702) |
71,347 |
|
10% |
|
| Sullivan John James |
Director |
– • – |
2020-02-26 |
4 |
S |
$263.39 |
$281,827 |
D/D |
(1,070) |
71,347 |
|
18% |
|
| Sullivan John James |
Director |
– • – |
2020-02-26 |
4 |
OE |
$51.85 |
$92,194 |
D/D |
1,070 |
72,417 |
|
- |
|
| Sullivan John James |
Director |
– • – |
2020-02-25 |
4 |
S |
$267.09 |
$2,191,741 |
D/D |
(8,206) |
71,347 |
|
17% |
|
| Sullivan John James |
Director |
– • – |
2020-02-25 |
4 |
OE |
$50.50 |
$417,381 |
D/D |
8,206 |
79,553 |
|
- |
|
| Archbold Brian David |
SVP of Continuous Improvement |
• – – |
2020-02-21 |
4 |
S |
$268.19 |
$32,987 |
D/D |
(123) |
232 |
|
20% |
|
| Schmieder John Bradley |
Director |
– • – |
2020-02-19 |
4 |
S |
$266.46 |
$479,628 |
D/D |
(1,800) |
73,437 |
|
21% |
|
| Dwyer Robert V |
Director |
– • – |
2020-02-13 |
4 |
S |
$258.62 |
$1,586,116 |
D/D |
(6,133) |
35,696 |
|
18% |
|
| Dwyer Robert V |
Director |
– • – |
2020-02-12 |
4 |
S |
$258.72 |
$353,670 |
D/D |
(1,367) |
41,829 |
|
14% |
|
| Schmieder John Bradley |
Director |
– • – |
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
118 |
75,237 |
|
- |
|
| Guillemin Evan |
Director |
– • – |
2019-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
35,848 |
|
- |
|
| Guillemin Evan |
Director |
– • – |
2019-12-16 |
4 |
S |
$251.31 |
$1,884,825 |
D/D |
(7,500) |
40,848 |
|
- |
|
| Schmieder John Bradley |
Director |
– • – |
2019-11-25 |
4 |
S |
$238.06 |
$166,642 |
D/D |
(700) |
75,119 |
|
- |
|
| Dwyer Robert V |
Director |
– • – |
2019-11-07 |
4/A |
OE |
$0.00 |
$0 |
D/D |
150 |
43,196 |
|
- |
|
| Dwyer Robert V |
Director |
– • – |
2019-11-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
150 |
57,718 |
|
- |
|
618 Records found
|
|
Page 11 of 25 |
|
|
2.61 (2.34%) 
